top of page

VYVANSE CAPSULES 40 mg

Product details

Registration number: SIN15842P

Classification: Prescription Only

Active ingredients: Lisdexamfetamine Dimesylate

Strength: 40.0 mg

Dosage form: CAPSULE

Route: ORAL

Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

ATC code: N06BA12

HSA approval date: 1 November 2019

Manufacturer(s):

  • Patheon Pharmaceuticals Inc. (Bulk Production)
  • Takeda GmbH

Manufacturing country/countries: UNITED STATES; GERMANY

What are the HSA registration number and classification for VYVANSE CAPSULES 40 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15842P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for VYVANSE CAPSULES 40 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Lisdexamfetamine Dimesylate

Strength: 40.0 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for VYVANSE CAPSULES 40 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: ORAL

Source for this answer

Who is the recorded registrant for VYVANSE CAPSULES 40 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for VYVANSE CAPSULES 40 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Patheon Pharmaceuticals Inc. (Bulk Production)
  • Takeda GmbH

Manufacturing country/countries: UNITED STATES; GERMANY

Source for this answer

Where can I look up VYVANSE CAPSULES 40 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15842P or the exact product name VYVANSE CAPSULES 40 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this VYVANSE CAPSULES 40 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this VYVANSE CAPSULES 40 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15842P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page